Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union
Pharmaceutical
Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union
Strength
Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union
Pack Size
Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union
Form
Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union
Source
European Medicines Agency
Safety Profile
Contraindications
Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union
Side Effects
Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union
Scan this QR code to access this page quickly on your mobile device.